| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |